Urokinase (UK) is a thrombolytic agent extracted from human fresh urine. It can activate plasminogen to plasmin, with the subsequent hydrolysis of fibrin and dissolution of thrombi.

 

This product is mainly used in the treatment of acute myocardial infarction, acute cerebral thrombosis, occlusion of cerebral blood vessel, peripheral arteriovenous thrombi, central retinal arteriovenous thrombi and other infarction diseases due to freshly formed clot

 

Haoran Biopharma can supply bulk UK with the following specifications. Products of various specifications can also be prepared according to customers' requests.

 

Appearance	White or almost white, amorphous powder
Identification	Identified
Activity	Not less than 80,000 IU/mg
Specific activity	Not less than 120,000 IU/mg protein
Clarity of solution	Clear
Thromboplastic contaminants	Not less than 150 IU/ml
HMW-Urokinase	Not less than 90%
Bacterial endotoxins	Not more than 1.0 EU /10,000 IU
Abnormal toxicity	Negative at 5000 IU/0.5ml/mouse
HIV I+II antibody	Negative
Hepatitis B surface antigen	Negative
HCV antibodies	Negative